Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Schembl19599628
2. Gtpl11232
3. Blu5937
4. Neo5937
5. Hy-135976
6. Cs-0119082
7. 2417288-67-4
8. Methyl (3s)-3-[[2-[2,6-difluoro-4-(methylcarbamoyl)phenyl]-7-methylimidazo[1,2-a]pyridin-3-yl]methyl]piperidine-1-carboxylate
| Molecular Weight | 456.5 g/mol |
|---|---|
| Molecular Formula | C24H26F2N4O3 |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 456.19729703 g/mol |
| Monoisotopic Mass | 456.19729703 g/mol |
| Topological Polar Surface Area | 75.9 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 701 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
45
PharmaCompass offers a list of BLU-5937 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right BLU-5937 manufacturer or BLU-5937 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred BLU-5937 manufacturer or BLU-5937 supplier.
PharmaCompass also assists you with knowing the BLU-5937 API Price utilized in the formulation of products. BLU-5937 API Price is not always fixed or binding as the BLU-5937 Price is obtained through a variety of data sources. The BLU-5937 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BLU-5937 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BLU-5937, including repackagers and relabelers. The FDA regulates BLU-5937 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BLU-5937 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A BLU-5937 supplier is an individual or a company that provides BLU-5937 active pharmaceutical ingredient (API) or BLU-5937 finished formulations upon request. The BLU-5937 suppliers may include BLU-5937 API manufacturers, exporters, distributors and traders.
BLU-5937 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BLU-5937 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right BLU-5937 GMP manufacturer or BLU-5937 GMP API supplier for your needs.
A BLU-5937 CoA (Certificate of Analysis) is a formal document that attests to BLU-5937's compliance with BLU-5937 specifications and serves as a tool for batch-level quality control.
BLU-5937 CoA mostly includes findings from lab analyses of a specific batch. For each BLU-5937 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BLU-5937 may be tested according to a variety of international standards, such as European Pharmacopoeia (BLU-5937 EP), BLU-5937 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BLU-5937 USP).
